HighTower Advisors, LLC - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2023$208,000
-42.1%
10,867
-22.8%
0.00%
-100.0%
Q2 2023$359,000
-28.5%
14,077
+1.1%
0.00%0.0%
Q1 2023$502,000
-7.9%
13,925
+1.1%
0.00%0.0%
Q4 2022$545,000
-36.0%
13,776
-24.5%
0.00%
-50.0%
Q3 2022$851,000
+9.2%
18,255
+2.8%
0.00%0.0%
Q2 2022$779,000
-38.9%
17,751
+0.7%
0.00%
-33.3%
Q1 2022$1,275,000
+3.2%
17,629
+15.7%
0.00%0.0%
Q4 2021$1,235,000
+2.3%
15,238
+46.8%
0.00%0.0%
Q3 2021$1,207,000
-29.1%
10,379
+1.0%
0.00%
-40.0%
Q2 2021$1,703,000
+18.1%
10,279
-0.5%
0.01%0.0%
Q1 2021$1,442,000
-43.6%
10,329
-30.1%
0.01%
-54.5%
Q4 2020$2,556,000
+17.4%
14,769
-5.5%
0.01%0.0%
Q3 2020$2,177,000
+41.3%
15,629
+21.0%
0.01%
+37.5%
Q2 2020$1,541,000
-17.9%
12,913
-31.3%
0.01%
-33.3%
Q1 2020$1,877,000
+4.8%
18,788
+23.3%
0.01%
+9.1%
Q4 2019$1,791,000
+53.5%
15,233
+12.1%
0.01%
+83.3%
Q3 2019$1,167,000
+98.8%
13,583
+50.0%
0.01%
+100.0%
Q2 2019$587,0009,0580.00%
Other shareholders
NEVRO CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders